117 reports of this reaction
1.6% of all CROMOLYN SODIUM reports
#14 most reported adverse reaction
ANAPHYLACTIC REACTION is the #14 most commonly reported adverse reaction for CROMOLYN SODIUM, manufactured by Prestige Brands Holdings, Inc.. There are 117 FDA adverse event reports linking CROMOLYN SODIUM to ANAPHYLACTIC REACTION. This represents approximately 1.6% of all 7,214 adverse event reports for this drug.
Patients taking CROMOLYN SODIUM who experience anaphylactic reaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAPHYLACTIC REACTION is a less commonly reported adverse event for CROMOLYN SODIUM, but still significant enough to appear in the safety profile.
In addition to anaphylactic reaction, the following adverse reactions have been reported for CROMOLYN SODIUM:
The following drugs have also been linked to anaphylactic reaction in FDA adverse event reports:
ANAPHYLACTIC REACTION has been reported as an adverse event in 117 FDA reports for CROMOLYN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAPHYLACTIC REACTION accounts for approximately 1.6% of all adverse event reports for CROMOLYN SODIUM, making it a notable side effect.
If you experience anaphylactic reaction while taking CROMOLYN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.